Tiny brain proteins mapped in aging tissue

These are microproteins: small proteins between one hundred and one hundred and fifty amino acids long. They are so small that they rarely appear in standard protein databases. As a result, they have been almost entirely absent from research on brain aging. The researchers published their findings in the journal Nature Aging, cataloguing more than one thousand high-confidence microproteins in brain tissue from older people.

One microprotein stands out in Alzheimer’s

Among those thousand candidates, one stands out. The microprotein produced by the MKKS gene is reduced in brain tissue from people with Alzheimer’s disease. Moreover, this small protein regulates energy production in microglia (the immune cells of the brain). That is relevant: microglia play a central role in the inflammatory process associated with Alzheimer’s.

The mechanism is not yet fully understood. The researchers describe an association, not a causal relationship. Whether this microprotein contributes to the onset or progression of Alzheimer’s, or is instead a consequence of the disease, cannot be determined from this study alone.

A new layer in protein research on aging

The atlas itself is the main contribution of this research. By systematically mapping microproteins in the aging brain, it creates a new reference layer for future work. Researchers can now search specifically for microproteins that change in particular brain conditions or during healthy aging.

For longevity science, this is of interest because the protein landscape of the cell turns out to be far larger than long assumed. Microproteins have been a blind spot until now. Whether any of them might eventually serve as biomarkers or therapeutic targets requires extensive follow-up research.

Read the original article